Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma.

4112Background: Adrenocortical carcinomas (ACC) are rare and aggressive. Treatment options are limited and marked by poor efficacy and substantial toxicity. In this phase II single-center study, th...